(Q38095485)

28 August 2017

title

Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles (English)

1 reference

28 August 2017

0 references

Eliana B Souto

2

0 references

author name string

Medha Patel

series ordinal

1

1 reference

28 August 2017

Kamalinder K Singh

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

4 April 2013

1 reference

Expert Opinion on Drug Delivery

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

889-905

1 reference

Parkinson's disease (PD) in the elderly: an example of geriatric syndrome (GS)?

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Between destiny and disease: genetics and molecular pathways of human central nervous system aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Translational CNS medicines research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Nanoparticle technology for drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Drug-loaded nanocarriers: passive targeting and crossing of biological barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Challenges in drug delivery to the brain: nature is against us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Recent advances in brain tumor-targeted nano-drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Targeting neurotherapeutic agents through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Alzheimer's disease drug development and the problem of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Why is the global CNS pharmaceutical market so under-penetrated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Astrocyte-endothelial interactions and blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Modelling of the blood-brain barrier in drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Novel delivery strategies for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Advances in strategies to improve drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid metabolism and glial lipoproteins in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Astrocytes: regulation of brain homeostasis via apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Molecular biology of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Drug and gene delivery to the brain: the vascular route

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Tight junctions of the blood-brain barrier: development, composition and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Property-based design: optimization of drug absorption and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

In silico prediction of blood–brain barrier permeation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Nano-interventions for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Potential of solid lipid nanoparticles in brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles for targeted brain drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Transport of drugs across the blood-brain barrier by nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid-based drug delivery systems for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Brain uptake of thiamine-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles for parenteral drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Preparation and characterization of solid lipid nanospheres containing paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The production and characteristics of solid lipid nanoparticles (SLNs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Structural investigations on lipid nanoparticles containing high amounts of lecithin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Comparison of wax and glyceride solid lipid nanoparticles (SLN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Influence of emulsifiers on the crystallization of solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Combinatorial nanoparticles for cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Body distribution of camptothecin solid lipid nanoparticles after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

In situ blood-brain barrier transport of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Paclitaxel nanoparticles for the potential treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Formulation and targeting efficiency of Cisplatin engineered solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxia-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Lipid nanomedicines for anticancer drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.784742

10.1517/17425247.2013.784742

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference